<DOC>
	<DOCNO>NCT01716338</DOCNO>
	<brief_summary>Glyburide medication safely use several decade treat non-insulin dependent diabetes . This pilot study seek evaluate whether glyburide , administer low dose ( 1.5 mg/dL daily ) healthy ( non-diabetic ) subject safe physically cognitively . The investigator hopeful result study provide necessary foundation evaluate medication 's use large scale determine feasibility use glyburide soldier either prophylactically treatment brain injury .</brief_summary>
	<brief_title>Glyburide Healthy Volunteer Study</brief_title>
	<detailed_description>This study placebo control ( 2:1 drug vs. placebo ) , randomize clinical trial 21 healthy , non-diabetic volunteer receive daily dos oral glyburide ( 1.5 mg ) vs. placebo careful medical monitoring inpatient Clinical Research Unit ( CRU ) within Center Applied Research Sciences ( CARS ) Washington University St. Louis Medical Center duration 7 day night ( 24 hour per day ) . Interested subject call information study schedule screen visit . Subjects participate first informed consent process , wish take part ask undergo comprehensive interview detail past medical history formal physical examination ( include laboratory test urine blood ) . If subject deem appropriate team , he/she ask perform exercise test ( treadmill 30 minute ) Electrocardiogram ( ECG ) complete determine eligibility . Individuals meet inclusion criterion base screen activity notify immediately eligible . Volunteers meet eligibility criterion schedule week long in-patient evaluation . Each subject undergo battery physical , cognitive , laboratory test addition receive oral glyburide placebo day one week .</detailed_description>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Volunteers age 18 40 . Have Body Mass Index ( BMI ) 1830 . Normal screen physical examination ( nonpregnant confirm serum Beta HcG , nondiabetic confirm normal Hgb A1C , normal baseline ECG vital sign , laboratory value within normal limit ( lab test include : complete blood count , electrolytes , liver function test , kidney function test , uric acid , cholesterol , iron , urinalysis , urine drug screen ; conduct within 2 week prior randomization ) . Women Childbearing Potential ( WCP ) demonstrate willingness use contraception method ( birth control medication ) prevent pregnancy time consent 30 day past last dose . **Note , birth control medication MAY BE use completion inpatient hospital phase study ( i.e . discharge ) . Unremarkable past medical history . Ability provide inform consent . Ability undergo physical exercise ( determine treadmill exercise test ensure physical fitness participant ) . Those experience fatigue , dizziness chest pain screen exercise test treadmill exclude . Ability undergo neuropsychological test attention , cognition , dexterity , etc . Willing remain inpatient set duration study . Use investigational drug within 4 week study . Using tobacco . Acute illness surgery within 4 week study . Allergic sulfonylurearelated drug . Presence pathological condition part body . Any medication within 2 week study , include oral contraceptive . Ingestion alcohol caffeine contain food beverage within 48 hour start study . History alcohol drug abuse , cardiac arrhythmia , psychotropic agent use , immunosuppressive condition ( i.e . HIV , AIDS , Cancer ) hepatitis . Donation blood within 3 month receive blood product within 14 day . Recent body tattoo piercing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>glyburide</keyword>
	<keyword>glybenclamide</keyword>
	<keyword>hypoglycemia</keyword>
</DOC>